On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosisRobert J Greenstein
Department of Surgery, Veterans Affairs Medical Center, Bronx, New York, United States of America
PLoS ONE 3:e2496. 2008
..Rapamycin and Tacrolimus are macrolides. We hypothesized that their mode of action may simply be to inhibit MAP growth...
Vitamins A & D inhibit the growth of mycobacteria in radiometric cultureRobert J Greenstein
Department of Surgery, James J Peters Veterans Affairs Medical Center, Bronx, New York, United States of America
PLoS ONE 7:e29631. 2012
..We hypothesized that some vitamins may directly influence the growth of prokaryotes, particularly mycobacteria...
Growth of M. avium subspecies paratuberculosis in culture is enhanced by nicotinic acid, nicotinamide, and ? and ? nicotinamide adenine dinucleotideRobert J Greenstein
Department of Surgery, James J Peters VAMC, Bronx, NY 10468, USA
Dig Dis Sci 56:368-75. 2011
..Mycobacterium avium subspecies paratuberculosis (MAP) may be zoonotic. We hypothesized that tobacco components might alter the growth kinetics of MAP, explaining these divergent clinical observations...
The thioamides methimazole and thiourea inhibit growth of M. avium Subspecies paratuberculosis in cultureRobert J Greenstein
Department of Surgery, James J Peters VA Medical Center, Bronx, New York, United States of America
PLoS ONE 5:e11099. 2010
..Because other thioamides treat tuberculosis, leprosy and M. avium complex, we hypothesized that a mode of action of some thioamide anti-thyrotoxicosis medications may include MAP growth inhibition...
Monensin causes dose dependent inhibition of Mycobacterium avium subspecies paratuberculosis in radiometric cultureRobert J Greenstein
Laboratory of Molecular Surgical Research, VAMC Bronx, NY 112, 130 West Kingsbridge Road, Bronx, NY 10468, USA
Gut Pathog 1:4. 2009
..We posit that the "Growth Enhancer" effect of Monensin may, at least in part, be due to inhibition of MAP in clinical or sub-clinical Johne's disease...
On the effect of thalidomide on Mycobacterium avium subspecies paratuberculosis in cultureRobert J Greenstein
VAMC Bronx NY 112, 130 West Kingsbridge Rd, Bronx, NY 10468, USA
Int J Infect Dis 13:e254-63. 2009
..We herein test the hypothesis that thalidomide may inhibit MAP growth...
On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosisRobert J Greenstein
Departments of Surgery and Laboratory of Molecular Surgical Research, VA Medical Center, Bronx, New York, United States of America
PLoS ONE 2:e516. 2007
..We concluded that their most plausible mechanism of action is as antiMAP antibiotics. We herein hypothesize that the mechanism of action of 5-ASA and/or sulfapyridine may also simply be to inhibit MAP growth...
On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosisRobert J Greenstein
Laboratory of Molecular Surgical Research, VA Medical Center, Bronx, New York, United States of America
PLoS ONE 2:e161. 2007
..We hypothesized that the clinical efficacy of methotrexate and 6-MP in IBD may be to simply inhibit the growth of MAP...
Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?Robert J Greenstein
Department of Surgery, VAMC Bronx (112, New York, NY 10468, USA
Lancet 364:396-7. 2004
Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's diseaseRobert J Greenstein
Department of Surgery and Director of the Laboratory of Molecular Surgical Research, VA Medical Center, Bronx, NY, USA
Lancet Infect Dis 3:507-14. 2003
..Rational studies to evaluate appropriate therapies to cure Crohn's disease are proposed...
Esophageal anatomy and function in laparoscopic gastric restrictive bariatric surgery: implications for patient selectionR J Greenstein
Surgery, VAMC, Bronx, NY, USA
Obes Surg 8:199-206. 1998
..The purpose of this study was to assess factors of clinical importance in morbidly obese patients having a laparoscopically adjustable gastric band (LAP-BAND) implanted in order to achieve weight loss...
Is there clinical, epidemiological and molecular evidence for two forms of Crohn's disease?R J Greenstein
Laboratory of Molecular Surgical Research, VAMC Bronx, NY 10468, USA
Mol Med Today 1:343-8. 1995
..If correct, this subclassification may provide key insights into the pathogenesis and differing host immune responses in Crohn's disease and also allow the development of more rational therapies...